ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Sanofi India reported Q2 2026 domestic growth of 8%, driven by a 14% surge in its diabetes business. PBT (before exceptional items) grew 19% YoY to INR 112 crores.
Sanofi India Q2 2026 domestic sales grew 8% YoY, led by a 14% surge in Insulins. Profit Before Tax (PBT) rose 19% YoY to ₹1,123 Mio.
Sanofi India reported Q2'26 domestic sales growth of 8% YoY, driven by a 14% surge in its diabetes business. Management is focusing on business model transformation and operational efficiency.